CBC Group
CBC Group is a healthcare-dedicated investment firm with a major presence across Asia.
- Healthcare and life sciences private equity investment firm
- Healthcare & Life Sciences PEF
- Tier I
Overview
CBC Group is a healthcare-dedicated investment firm with a major presence across Asia. Its platform spans private equity, private credit, real estate, and other healthcare-related capital strategies, with investment exposure across biopharma, life sciences, medical technology, care delivery, and pharmaceutical infrastructure.
The firm’s Asian network gives it a distinctive position in markets where healthcare demand, domestic innovation, manufacturing capability, and private care infrastructure are developing rapidly. CBC can support companies seeking regional scale while connecting Asian healthcare businesses with global capital and commercial relationships. Within The Economy Wiki, the firm is connected to the Healthcare & Life Sciences PEF market category.
Firm facts
| Institution | CBC Group |
| Type | Healthcare and life sciences private equity investment firm |
| Headquarters | Singapore |
| Founded | 2014 |
| Primary ranking focus | Healthcare & Life Sciences PEF |
| Highest 2026 tier | Tier I |
Activities and investment capabilities
CBC’s announced combination with GHO Capital is intended to connect investment capabilities across Asia-Pacific, Europe, and North America. Until the transaction closes, CBC continues to operate as a separately identifiable platform and is assessed on that basis.
Healthcare investing
Equity investment across healthcare services, products and technology.
Life sciences exposure
Capital for pharmaceutical, biotechnology, medtech and outsourced-service platforms.
Sector value creation
Support informed by regulation, reimbursement, clinical workflows and market access.
Strategy and transaction coverage
Strategy and sector coverage
Healthcare services; life sciences; pharmaceuticals; medtech; diagnostics; healthcare IT
Transaction and ownership contexts
Buyouts; growth investments; recapitalizations; platform formation; add-on acquisitions
Market position
CBC Group fits Tier I because of its dedicated healthcare identity, approximately $10.8 billion in assets under management, regional influence, and importance in connecting Asian healthcare markets with the wider global investment ecosystem.
CBC Group is assessed within the Healthcare & Life Sciences PEF framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.
Competitive context
CBC Group is recognized Tier I in Top 30 Healthcare & Life Sciences PEF 2026. The ranking compares firms by institutional relevance, specialist capability, investment activity, operating depth and market positioning. Comparable-firm links below support navigation and do not imply that every institution competes for every transaction or asset.
Leadership and governance
Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through CBC Group’s official website.
| Leadership area | Current source |
|---|---|
| Investment and operating leadership | Current team and governance information |
Corporate and public information
This profile refers to CBC Group as the public-facing investment organization. Individual funds, management companies, advisers and regulated entities may use separate legal names across jurisdictions.
Corporate and disclosure information
| Organization | CBC Group |
| Headquarters | Singapore |
| Public website | www.cbridgecap.com |
| Profile basis | Public institutional information and Capital Ranking editorial research |
Ranking recognition
Related Economy analysis
Selected Economy Markets articles provide context for the investment, diligence, financing and value-creation themes relevant to this firm:
- The Mid-Market Advantage in Healthcare Private Equity
- Middle-Market Private Equity: Returns, Scale and Manager Selection
- Private Equity Technology Due Diligence in the AI Era
